within Pharmacolibrary.Drugs.ATC.D;

model D08AK06
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 3.3333333333333335e-07,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D08AK06</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Thiomersal (also known as thimerosal) is an organomercury compound with antiseptic and antifungal properties. It has been used as a preservative in vaccines, antivenoms, and various pharmaceutical and cosmetic products. Its use in vaccines has been significantly reduced or eliminated in many countries due to concerns about mercury exposure, although it is still used in some multidose vial vaccines.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic models or parameters were identified for thiomersal or its main metabolite, ethylmercury, in the general healthy adult population. Most data are indirect, with some limited animal studies or estimates based on mercury exposure.</p><h4>References</h4><ol><li><p>Blanco-Príeto, MJ, et al., &amp; Gander, B (2000). In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. <i>Journal of controlled release : official journal of the Controlled Release Society</i> 67(1) 19–28. DOI:<a href=&quot;https://doi.org/10.1016/s0168-3659(99)00289-8&quot;>10.1016/s0168-3659(99)00289-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10773325/&quot;>https://pubmed.ncbi.nlm.nih.gov/10773325</a></p></li><li><p>Pichichero, ME, et al., &amp; Treanor, J (2008). Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. <i>Pediatrics</i> 121(2) e208–e214. DOI:<a href=&quot;https://doi.org/10.1542/peds.2006-3363&quot;>10.1542/peds.2006-3363</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18245396/&quot;>https://pubmed.ncbi.nlm.nih.gov/18245396</a></p></li><li><p>Harry, GJ, et al., &amp; Burka, LT (2004). Mercury concentrations in brain and kidney following ethylmercury, methylmercury and Thimerosal administration to neonatal mice. <i>Toxicology letters</i> 154(3) 183–189. DOI:<a href=&quot;https://doi.org/10.1016/j.toxlet.2004.07.014&quot;>10.1016/j.toxlet.2004.07.014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15501610/&quot;>https://pubmed.ncbi.nlm.nih.gov/15501610</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D08AK06;
